Pitfalls

Syniverse to Explore the Future of Connectivity at 2024 Acceleration Exchange Conference

Retrieved on: 
Donnerstag, Mai 2, 2024

"We must keep customers seamlessly connected during the transition to 5G technology while helping operators uncover new ways to generate revenue," said Paul Hodges, Syniverse's Senior Vice President of Asia Pacific.

Key Points: 
  • "We must keep customers seamlessly connected during the transition to 5G technology while helping operators uncover new ways to generate revenue," said Paul Hodges, Syniverse's Senior Vice President of Asia Pacific.
  • "By bringing so many trusted partners together under one roof, we're facilitating conversations that will fundamentally shape the future of connectivity throughout the APAC region and beyond."
  • The day will conclude with concurrent sessions on mobility solutions and messaging solutions.
  • For more information on Syniverse, visit https://www.syniverse.com .

Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting

Retrieved on: 
Mittwoch, Februar 21, 2024

Apyx Medical Corporation (Nasdaq: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that its Renuvion technology will be featured in three educational sessions at the upcoming American Academy of Cosmetic Surgery’s 40th Annual Scientific Meeting, to be held in New Orleans, LA from February 22 – 24.

Key Points: 
  • Apyx Medical Corporation (Nasdaq: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that its Renuvion technology will be featured in three educational sessions at the upcoming American Academy of Cosmetic Surgery’s 40th Annual Scientific Meeting, to be held in New Orleans, LA from February 22 – 24.
  • “Apyx Medical is pleased to see Renuvion featured in a variety of insightful educational presentations during AACS 2024, which we believe will help to expand the awareness of our Helium Plasma Technology and its benefits,” said Charlie Goodwin, President and Chief Executive Officer of Apyx Medical.
  • Demographic, procedure and safety data were collected and evaluated from a contiguous series of more than 450 patients, including 229 patients treated with Renuvion and 236 patients treated with Bipolar RF.
  • The researchers analyzed adverse events recorded by the body area during or post-procedure for each group.

NYU Stern School of Business Partners with NYU Abu Dhabi to Launch One-year Full-time MBA Program in the UAE

Retrieved on: 
Dienstag, September 19, 2023

NYU President Linda G. Mills said, "The establishment of the Stern at NYUAD MBA is truly a landmark occasion. The launch of this program – NYUAD's first professional degree offering, created in collaboration with NYU's Stern School -- is an important new stage in NYU Abu Dhabi's successful development, and a major step forward in fulfilling the vision that NYU and our Abu Dhabi partners have had for this groundbreaking institution from the beginning. It is also a wonderful example of the type of cross-school collaboration that we can expect to see more of in the coming years, and I have no doubt its impact will be felt both regionally and globally."

Key Points: 
  • New York University's Stern School of Business is the only top US business school offering a full-time MBA program in the Middle East.
  • The Stern at NYU Abu Dhabi One-year Full-time MBA Program will give students the opportunity to build future careers in the MENA region, with educational modules in both Abu Dhabi and New York.
  • ABU DHABI, UAE, Sept. 19, 2023 /PRNewswire/ -- The NYU Stern School of Business (NYU Stern), one of the world's premier research and teaching institutions, and NYU Abu Dhabi (NYUAD), an exceptional liberal arts and research university, today announced the launch of the Stern at NYUAD One-year Full-time MBA Program.
  • On successful completion of the MBA program, students will graduate with a fully accredited New York University degree, jointly conferred by NYU Stern and NYU Abu Dhabi.

NYU Stern School of Business Partners with NYU Abu Dhabi to Launch One-year Full-time MBA Program in the UAE

Retrieved on: 
Dienstag, September 19, 2023

NYU President Linda G. Mills said, "The establishment of the Stern at NYUAD MBA is truly a landmark occasion. The launch of this program – NYUAD's first professional degree offering, created in collaboration with NYU's Stern School -- is an important new stage in NYU Abu Dhabi's successful development, and a major step forward in fulfilling the vision that NYU and our Abu Dhabi partners have had for this groundbreaking institution from the beginning. It is also a wonderful example of the type of cross-school collaboration that we can expect to see more of in the coming years, and I have no doubt its impact will be felt both regionally and globally."

Key Points: 
  • New York University's Stern School of Business is the only top US business school offering a full-time MBA program in the Middle East.
  • The Stern at NYU Abu Dhabi One-year Full-time MBA Program will give students the opportunity to build future careers in the MENA region, with educational modules in both Abu Dhabi and New York.
  • ABU DHABI, UAE, Sept. 19, 2023 /PRNewswire/ -- The NYU Stern School of Business (NYU Stern), one of the world's premier research and teaching institutions, and NYU Abu Dhabi (NYUAD), an exceptional liberal arts and research university, today announced the launch of the Stern at NYUAD One-year Full-time MBA Program.
  • On successful completion of the MBA program, students will graduate with a fully accredited New York University degree, jointly conferred by NYU Stern and NYU Abu Dhabi.

Wolters Kluwer Experts Share Insights on the Dangers of Predatory Lending Practices

Retrieved on: 
Mittwoch, Juli 19, 2023

Business owners should be aware of factors that can lead to predatory practices and how those risks can be mitigated to help ensure fair lending practices.

Key Points: 
  • Business owners should be aware of factors that can lead to predatory practices and how those risks can be mitigated to help ensure fair lending practices.
  • Jason Keller and Emily Redig of Wolters Kluwer Compliance Solutions recently shared their insights on how business owners can avoid unscrupulous actors that provide short-term borrowing solutions with unreasonable terms.
  • The insights are detailed in a feature article, “ Avoiding the Pitfalls of Predatory Lending in a High-Rate Environment ,” published in Corporate Compliance Insights.
  • “In periods of inflation and potentially stressed economic times, lenders must be mindful of fair lending laws and regulations that are, in part, intended to prevent predatory lending,” they write.

HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights

Retrieved on: 
Dienstag, Mai 9, 2023

MIRAMAR, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its first quarter ended March 31, 2023.

Key Points: 
  • MIRAMAR, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its first quarter ended March 31, 2023.
  • Publishing ground-breaking scientific papers,” stated Dr. Hing C. Wong, Founder and CEO of HCW Biologics.
  • First Quarter 2023 Financial Results:
    Revenues: Revenues for the first quarter ended March 31, 2022 and 2023 were $3.1 million and $41,883, respectively.
  • Net loss: Net loss for the first quarter ended March 31, 2022 and 2023 was $2.1 million and $5.1 million, respectively.

ASSEMBLY EXPANDS INDUSTRY-LEADING POLITICS AND ADVOCACY PRACTICE WITH THE LAUNCH OF NEW ADVOCACY CONSULTING TECHNOLOGY (ACT) PLATFORM

Retrieved on: 
Donnerstag, Mai 4, 2023

NEW YORK, May 4, 2023 /PRNewswire/ -- Global omnichannel media agency Assembly is launching ACT, a first-of-its-kind platform that allows public figures and brands alike to proactively guard against woke washing, greenwashing, rainbow washing, and other types of performative advocacy. Powered by STAGE, Assembly's proprietary technology, ACT tracks cause or policy-forward advertising content, spend, and performance across mediums to inform buying and messaging strategy while identifying what percentage of advertising has favorable or unfavorable effects on brand reputation. ACT is the latest innovation from Assembly's industry-leading politics and advocacy practice, launched in 2019, to handle planning, activation, and strategy for some of the most high-profile candidates and independent expenditure groups in the country. 

Key Points: 
  • ACT is the latest innovation from Assembly's industry-leading politics and advocacy practice, launched in 2019, to handle planning, activation, and strategy for some of the most high-profile candidates and independent expenditure groups in the country.
  • ACT tracks cause or policy-forward advertising content, spend, and performance to inform buying and messaging strategy.
  • Bridging the findings of this study with insights from ACT, Assembly recently published a whitepaper titled, " Avoiding the Pitfalls of Performative Advocacy ."
  • "ACT is the missing piece to the brand responsibility puzzle, and we're proud to be on the cutting edge."

New CFO Study Highlights a Dangerous Disconnect Within UK Businesses in Planning for Cyber-Attacks

Retrieved on: 
Donnerstag, Mai 26, 2022

The findings laid bare the disconnect in how senior management teams collaborate and determine the risks and impact on their operations when hit by a cyber-attack.

Key Points: 
  • The findings laid bare the disconnect in how senior management teams collaborate and determine the risks and impact on their operations when hit by a cyber-attack.
  • This implies a significant perception disconnect compared with the 63% of CEOs who feel they are well-prepared.
  • To get your copy of Dangerous Disconnects: The Pitfalls of CFO and CISO Cyber Risk Misalignment, please click here .
  • We predict and prevent known, unknown, and zero-day threats in

CDRI Adds Respected Industry Leader to Its Board of Directors

Retrieved on: 
Montag, Mai 23, 2022

WASHINGTON, May 23, 2022 /PRNewswire-PRWeb/ -- Today, the Consumer Debt Relief Initiative (CDRI) — the premier industry organization dedicated to the protection and promotion of the debt settlement industry — announced the expansion of its board of directors to include Michael Barsoum, CEO of Alleviate Financial Solutions. The association's rapid growth and this strategic addition better position the organization to thrive, particularly as the evolution of the FinTech space continues.

Key Points: 
  • Michael Barsoum, CEO of Alleviate Financial Solutions, brings 20 years of success in the financial industry to Consumer Debt Relief Initiative's board of directors.
  • WASHINGTON, May 23, 2022 /PRNewswire-PRWeb/ -- Today, the Consumer Debt Relief Initiative (CDRI) the premier industry organization dedicated to the protection and promotion of the debt settlement industry announced the expansion of its board of directors to include Michael Barsoum, CEO of Alleviate Financial Solutions.
  • "Since our founding just 18 months ago, CDRI has become a respected and effective voice for the debt settlement industry," said Tomas Gordon, CDRI founder and president of its board of directors.
  • "I look forward to helping CDRI attain continued growth, achieve its objectives and remain a primary advocate for the industry."

Labroots Announces 5th Annual Drug Discovery & Development Online Event, hosted on February 23, 2022

Retrieved on: 
Donnerstag, Februar 17, 2022

Marking the 5th year, the symposium features another exciting lineup of invited prominent speakers spanning key topics and sharing new discoveries and advancements with the scientific community.

Key Points: 
  • Marking the 5th year, the symposium features another exciting lineup of invited prominent speakers spanning key topics and sharing new discoveries and advancements with the scientific community.
  • Drug Discovery & Development 2022 promises to deliver a comprehensive agenda including sessions ranged from novel approaches to drug discovery and preclinical development, to explorations into PK/PD and Pharmacogenomics, and lastly a peek into advancements in clinical development.
  • "Now in its 5th year, we are proud to provide a unique and highly valuable platform for inspiring interdisciplinary exchange at the forefront of drug discovery, a rapidly evolving field, via our Drug Discovery & Development virtual event," said Greg Cruikshank, Chief Executive Officer of Labroots.
  • Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities.